C3887460||Cardiometabolic
C0005516||Biomarkers
C0007222||cardiovascular disease
C0007222||cardiovascular disease
C0005516||biomarker
C0043210||women
C0025266||men
C0683971||general population
C0936012||analyzed
C0005516||biomarkers
C0043210||women
C0025266||men
C0007222||cardiovascular disease
C0035648||risk factors
C0018787||cardiac
C0010362||cross-sectional analysis
C0681876||Dallas Heart Study
C0681876||multiethnic population-based study
C0005516||biomarkers
C0683312||categories
C0220825||evaluated
C0034510||race
C0007222||cardiovascular disease
C0035648||risk factors
C0232804||kidney function
C0021655||insulin resistance
C0024485||MRI
C1510486||dual-energy x-ray absorptiometry
C0424621||fat distribution
C0455825||left ventricular mass
C0679646||participants
C0007222||cardiovascular disease
C2348561||study population
C0027361||individuals
C0043210||women
C0005680||black
C0683312||categories
C0005516||biomarkers
C0023779||lipids
C1955907||adipokines
C0005516||biomarkers
C0021368||inflammation
C0856169||endothelial dysfunction
C0596981||myocyte
C1516360||stress
C0232804||kidney function
C0043210||women
C0023822||high-density lipoprotein cholesterol
C0023821||high-density lipoprotein particle
C0299583||leptin
C0060323||d-dimer
C0019877||homoarginine
C0754710||N-terminal pro B-type natriuretic peptide
C0023824||low-density lipoprotein cholesterol
C0389071||adiponectin
C0023820||lipoprotein
C0031667||phospholipase A2
C0243102||activity
C0128897||monocyte chemoattractant protein-1
C3253526||endothelial cell adhesion molecule
C0332516||symmetrical
C1453836||dimethylarginine
C0332514||asymmetrical
C1453836||dimethylarginine
C0077404||troponin T
C0071744||cystatin C
C0005516||Biomarker
C0043210||women
C0025266||men
C0683971||general population
C0005516||biomarkers
C0856169||endothelial dysfunction
C0243095||inflammatory cell recruitment
C2317276||cardiac stress
C0018805||injury
C0005516||biomarkers
C0009566||complications
C0007222||cardiovascular disease